"Kernodle Clinic West houses multiple Duke Health clinics. To see which providers and services are offered at these clinics, please click on the individual clinic links below."

During the past decade, Kernodle Clinic Inc. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 8 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kernodle Clinic Inc." #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Novartis" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Cogentus Pharmaceuticals" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kernodle Clinic Inc." #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kernodle Clinic Inc." are "Diabetes Mellitus, Type 2" (4 trials), "Atrial Fibrillation" (2 trials), "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Respiratory Infection" (1 trials). Many other conditions were trialed in "Kernodle Clinic Inc." in a lesser frequency.

Most popular intervention types in "Kernodle Clinic Inc." are "Drug" (12 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Fesoterodine 4mg" (1 trials) and "Fesoterodine 8mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kernodle Clinic Inc." are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kernodle Clinic Inc.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Kernodle Clinic Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kernodle Clinic Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".